top of page
Tadalafil

他達拉非
Mechanism of action:
Tadalafil 是一種第 5 型磷酸二酯酶抑制劑(phosphodiesterase type 5 inhibitor)。第 5 型磷酸二酯酶(phosphodiesterase type 5)是負責分解環磷酸鳥苷(cGMP)的酵素,在陰莖海綿體與肺血管平滑肌中特別豐富。Tadalafil 可選擇性抑制此酵素,減少 cGMP 的降解。cGMP 會活化蛋白激酶 G(protein kinase G),使細胞內鈣離子濃度下降,海綿體與血管平滑肌放鬆,血流量增加。
Reference(s):
1. Forgue ST et al. (2006). Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol.
2. Andersson KE et al. (2018). PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery. Br J Pharmacol.
3. Arif SA et al. (2011). Tadalafil: a long-acting phosphodiesterase-5 inhibitor for the treatment of pulmonary arterial hypertension. Clin Ther.
bottom of page
